癫痫识别与用药安全：从首次发作到长期管理

先看懂四件事：癫痫怎么定义、首次发作怎么办、药怎么选、什么情况考虑手术Epilepsy

癫痫管理的核心是「明确诊断 → 选对药物 → 长期规律服药 → 控制不佳时评估手术」：诊断要靠发作史与检查综合判断，治疗要以最小有效剂量实现无发作并兼顾副作用，育龄女性还需提前规划用药。

发病机理：神经元异常同步放电与复发机制Pathogenesis

癫痫发作的本质是脑内神经元异常同步放电；是否复发取决于病因、脑电图特征与诱因，而治疗的目标是减少放电、预防复发，同时把药物副作用控制到最低。

哪些因素增加发作与复发风险

两个容易被忽略的问题

怎么检查：脑电图、影像与评估Assessment

怎么用药：单药选择、特殊人群与手术Treatment

治疗方式一览

日常管理：怎么安全生活：发作日记与安全防护Daily Management

十个常见误区Ten Common Misconceptions

参考文献与证据来源References & Evidence

本页共 24 条文献，来自国际共识与指南、随机对照试验、荟萃分析与机制研究，链接指向 PubMed。每条结论后的编号对应下方文献；证据不足或结论不一致之处已在正文标注。

1. ILAE 癫痫分类立场文件Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW, Moshé SL, Nordli DR, Perucca E, Tomson T, Wiebe S, Zhang YH, Zuberi SM. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512-521. pubmed.ncbi.nlm.nih.gov/28276062
2. ILAE 发作类型操作分类Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, Lagae L, Moshé SL, Peltola J, Roulet Perez E, Scheffer IE, Zuberi SM. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522-530. pubmed.ncbi.nlm.nih.gov/28276060
3. ILAE 报告（癫痫的实用临床定义）Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, Engel J, Forsgren L, French JA, Glynn M, Hesdorffer DC, Lee BI, Mathern GW, Moshé SL, Perucca E, Scheffer IE, Tomson T, Watanabe M, Wiebe S. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475-482. pubmed.ncbi.nlm.nih.gov/24730690
4. AAN 循证指南（成人首次无诱因发作的管理）Krumholz A, Wiebe S, Gronseth GS, Gloss DS, Sanchez AM, Kabir AA, Liferidge AT, Martello JP, Kanner AM, Shinnar S, Hopp JL, French JA. Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2015;84(16):1705-1713. pubmed.ncbi.nlm.nih.gov/25901057
5. 随机对照试验（立即与延迟抗癫痫药物治疗：MESS）Marson A, Jacoby A, Johnson A, Kim L, Gamble C, Chadwick D, Medical Research Council MESS Study Group. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet (London, England). 2005;365(9476):2007-2013. pubmed.ncbi.nlm.nih.gov/15950714
6. 随机试验再分析（首次发作后复发风险与驾驶建议）Bonnett LJ, Tudur-Smith C, Williamson PR, Marson AG. Risk of recurrence after a first seizure and implications for driving: further analysis of the Multicentre study of early Epilepsy and Single Seizures. BMJ (Clinical research ed.). 2010;341():c6477. pubmed.ncbi.nlm.nih.gov/21147743
7. 研究（首次发作患者的动态脑电图与睡眠脑电图比较）Geut I, Weenink S, Knottnerus ILH, van Putten MJAM. Detecting interictal discharges in first seizure patients: ambulatory EEG or EEG after sleep deprivation? Seizure. 2017;51():52-54. pubmed.ncbi.nlm.nih.gov/28797915
8. 随机对照试验（常用抗癫痫药疗效比较：SANAD）Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR, SANAD Study group. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet (London, England). 2007;369(9566):1000-1015. pubmed.ncbi.nlm.nih.gov/17382827
9. 随机对照试验（左乙拉西坦等药物在局灶性癫痫中的比较：SANAD II）Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE, SANAD II collaborators. The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet (London, England). 2021;397(10282):1363-1374. pubmed.ncbi.nlm.nih.gov/33838757
10. 随机对照试验（丙戊酸与左乙拉西坦在全面性癫痫中的比较：SANAD II）Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE, SANAD II collaborators. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet (London, England). 2021;397(10282):1375-1386. pubmed.ncbi.nlm.nih.gov/33838758
11. 前瞻登记研究（英国癫痫与妊娠登记：抗癫痫药畸形风险）Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, Irwin B, McGivern RC, Morrison PJ, Craig J. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. Journal of neurology, neurosurgery, and psychiatry. 2006;77(2):193-198. pubmed.ncbi.nlm.nih.gov/16157661
12. 全国队列研究（孕期丙戊酸暴露与孤独症谱系障碍风险）Christensen J, Grønborg TK, Sørensen MJ, Schendel D, Parner ET, Pedersen LH, Vestergaard M. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA. 2013;309(16):1696-1703. pubmed.ncbi.nlm.nih.gov/23613074
13. 队列研究（不同抗癫痫药组合的重大先天畸形风险比较）Cohen JM, Alvestad S, Suarez EA, Schaffer A, Selmer RM, Havard A, Bateman BT, Cesta CE, Zoega H, Odsbu I, Huybrechts KF, Kjerpeseth LJ, Straub L, Leinonen MK, Bjørk MH, Nørgaard M, Gissler M, Ulrichsen SP, Hernandez-Diaz S, Tomson T, Furu K. Comparative Risk of Major Congenital Malformations With Antiseizure Medication Combinations vs Valproate Monotherapy in Pregnancy. Neurology. 2024;102(2):e207996. pubmed.ncbi.nlm.nih.gov/38165339
14. 前瞻队列研究（孕期抗癫痫药暴露儿童的 3 岁认知结局：MONEAD）Meador KJ, Cohen MJ, Loring DW, Matthews AG, Brown C, Robalino CP, Birnbaum AK, Voinescu PE, Kalayjian LA, Gerard EE, Gedzelman ER, Hanna J, Cavitt J, Sam M, French JA, Hwang S, Pack AM, Pennell PB, MONEAD Investigator Group. Cognitive outcomes at age 3 years in children with fetal exposure to antiseizure medications (MONEAD study) in the USA: a prospective, observational cohort study. The Lancet. Neurology. 2023;22(8):712-722. pubmed.ncbi.nlm.nih.gov/37479375
15. 随机对照试验（左乙拉西坦、磷苯妥英与丙戊酸治疗已发生的癫痫持续状态：ESETT）Chamberlain JM, Kapur J, Shinnar S, Elm J, Holsti M, Babcock L, Rogers A, Barsan W, Cloyd J, Lowenstein D, Bleck TP, Conwit R, Meinzer C, Cock H, Fountain NB, Underwood E, Connor JT, Silbergleit R, Neurological Emergencies Treatment Trials, Pediatric Emergency Care Applied Research Network investigators. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Lancet (London, England). 2020;395(10231):1217-1224. pubmed.ncbi.nlm.nih.gov/32203691
16. 随机对照试验（院前肌注与静脉给药治疗癫痫持续状态）Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, Barsan W, NETT Investigators. Intramuscular versus intravenous therapy for prehospital status epilepticus. The New England journal of medicine. 2012;366(7):591-600. pubmed.ncbi.nlm.nih.gov/22335736
17. 实践指南摘要（癫痫猝死的发生率与危险因素）Harden C, Tomson T, Gloss D, Buchhalter J, Cross JH, Donner E, French JA, Gil-Nagel A, Hesdorffer DC, Smithson WH, Spitz MC, Walczak TS, Sander JW, Ryvlin P. Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2017;88(17):1674-1680. pubmed.ncbi.nlm.nih.gov/28438841
18. 全国人群队列研究（癫痫猝死的发生率）Sveinsson O, Andersson T, Carlsson S, Tomson T. The incidence of SUDEP: A nationwide population-based cohort study. Neurology. 2017;89(2):170-177. pubmed.ncbi.nlm.nih.gov/28592455
19. ILAE 工作组共识（药物难治性癫痫的定义）Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshé SL, Perucca E, Wiebe S, French J. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069-1077. pubmed.ncbi.nlm.nih.gov/19889013
20. 随机对照试验（颞叶癫痫的手术治疗）Wiebe S, Blume WT, Girvin JP, Eliasziw M, Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. The New England journal of medicine. 2001;345(5):311-318. pubmed.ncbi.nlm.nih.gov/11484687
21. 随机对照试验（生酮饮食、改良阿特金斯饮食与低升糖指数饮食的疗效比较）Sondhi V, Agarwala A, Pandey RM, Chakrabarty B, Jauhari P, Lodha R, Toteja GS, Sharma S, Paul VK, Kossoff E, Gulati S. Efficacy of Ketogenic Diet, Modified Atkins Diet, and Low Glycemic Index Therapy Diet Among Children With Drug-Resistant Epilepsy: A Randomized Clinical Trial. JAMA pediatrics. 2020;174(10):944-951. pubmed.ncbi.nlm.nih.gov/32761191
22. 调查研究（中国癫痫患病率与治疗缺口）Wang WZ, Wu JZ, Wang DS, Dai XY, Yang B, Wang TP, Yuan CL, Scott RA, Prilipko LL, de Boer HM, Sander JW. The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study. Neurology. 2003;60(9):1544-1545. pubmed.ncbi.nlm.nih.gov/12743252
23. 疾病负担建模分析（中国癫痫负担趋势与预测）Fang Z, Wang F, Mei Z, Huang X, Gao L, Zheng L, Lin Y, Hu X. Trends in the burden of epilepsy in China from 1990 to 2021 and its forecast until 2044: based on the 2021 Global Burden of Disease study. QJM : monthly journal of the Association of Physicians. 2025;118(6):434-441. pubmed.ncbi.nlm.nih.gov/39913431
24. 随机临床试验（运动项目对癫痫患者健康的影响）Häfele CA, Rombaldi AJ, Feter N, Häfele V, Gervini BL, Domingues MR, da Silva MC. Effects of an exercise program on health of people with epilepsy: A randomized clinical trial. Epilepsy & behavior : E&B. 2021;117():107904. pubmed.ncbi.nlm.nih.gov/33740496